Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of Sunday, August 23, 2026.
Forward PE Ratio (N/A) = Close Price ($145.13) / Consensus Forward EPS ($-8.50)
FORWARD PE RATIO
N/A
Moderna, Inc.
Market Cap
$57.59B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Moderna, Inc. (MRNA) | $57.59B | N/A |
| Cardinal Health, Inc. (CAH)vs › | $53.75B | 21.30 |
| Cencora, Inc. (COR)vs › | $61.88B | 17.79 |
| Becton, Dickinson and Company (BDX)vs › | $52.90B | 15.15 |
| Edwards Lifesciences Corporation (EW)vs › | $51.70B | 29.92 |
| Humana Inc. (HUM)vs › | $45.49B | 41.39 |
| Agilent Technologies, Inc. (A)vs › | $44.89B | 26.24 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.93B | 37.70 |
| IQVIA Holdings Inc. (IQV)vs › | $42.77B | 20.04 |
| Cigna Corporation (CI)vs › | $73.33B | 9.10 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus next-FY EPS
At today's $145.13 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-8.50 | $-10.46 – $-7.93 | 16 | n/m |
| 2027-12-31 | $-4.88 | $-7.48 – $-3.41 | 15 | n/m |
| 2028-12-31 | $-2.75 | $-4.64 – $0.53 | 14 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
